Updated Global Initiative for Obstructive Lung Disease (GOLD) strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease.
Pulmonary rehabilitation (PR) has demonstrated physiological, symptom-reducing, psychosocial, and health economic benefits for patients with chronic respiratory diseases, yet it is underutilized worldwide. The aim of this statement is to enhance the implementation, use, and delivery of pulmonary rehabilitation to suitable individuals.
This American Thoracic Society and European Respiratory Society statement reviews limb muscle dysfunction which is a key systemic consequence of COPD impacting on physical activity, exercise tolerance, quality of life, and even survival.
Pulmonary rehabilitation reduces breathlessness, increases exercise capacity, and improves quality of life in patients with chronic obstructive pulmonary disease (COPD). This Statement from the American Thoracic society and European Respiratory society provides a detailed update in the science and evolution of the concept of pulmonary rehabilitation.
Current evidence on the efficacy of insertion of endobronchial valves for lung volume reduction in emphysema shows some clinical and quality-of-life benefits. The U.K. National Institute for Health and Clinical Excellence (NICE) recommends they should only be used with special arrangements for clinical governance, consent and audit or research.
Canadian Thoracic Society (CTS) guidelines on quality of spirometry testing in primary care
U.K. National Institute for Health and Clinical Excellence (NICE) guidelines on the management of chronic obstructive pulmonary disease in adults in primary and secondary care. This update places an emphasis on clinical features of the disease and not over-reliance on spirometry and includes a comprehensive new section on inhaled therapies.
UK National Institute for Health and Clinical Excellence (NICE) technology appraisal guideline recommends that Roflumilast is used only as part of a clinical trial for adults with severe chronic obstructive pulmonary disease (COPD) (post-bronchodilator FEV1 < 50% predicted) with a history of frequent exacerbations as an add-on to bronchodilator treatment.
A Canadian Thoracic Society clinical practice evidence based guideline. This statement supports targeted testing for A1AT deficiency in patients with COPD diagnosed before 65 years of age or with a smoking history of less than 20 pack years.
This document from the American Thoracic Society discuss the problems faced in the care of patients with COPD, defines the interrelated concepts of integrated care and chronic disease management as they may apply to this disease, and present strategies currently in use.
This quality standard from the U.K. National Institute for Health and Clinical excellence covers the assessment, diagnosis and clinical management of chronic obstructive pulmonary disease (COPD) in adults and describes markers of high-quality, cost-effective care that, when delivered collectively, should contribute to improving the effectiveness, safety and experience of care for people with COPD.
UK National Institute for Health and Clinical Excellence (NICE) guide for commissioners, clinicians and managers to commission high quality and evidence based services across England.
A Clinical Practice Guideline Update from the American College of Physicians (ACP), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), and European Respiratory Society(ERS) on the diagnosis and management of stable Chronic Obstructive Pulmonary disease.
IMPRESS is a joint initiative between the British Thoracic Society (BTS) and the Primary Care Respiratory Society-UK (PCRS-UK). This evidence based document explains what Pulmonary Rehabilitation is, how it works, its value and why it should be commissioned.
A Canadian Thoracic Society clinical evidence based practice guideline supports the benefits of oral opioids, neuromuscular electrical stimulation, chest wall vibration, walking aids and pursed-lip breathing in the management of dyspnea in patients with advanced COPD. Oxygen is recommended for COPD patients with resting hypoxemia who receive symptomatic benefit from it.
An American Thoracic Society (ATS) Public Policy Statement reviewing the literature evaluating the impact of risk factors other than cigarette smoking for COPD
A Canadian Thoracic Society evidence based Clinical Practice Guideline. Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease – practical issues.